Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
QNCX —
QUINCE THERAPEUTICS INC
CUSIP: 22053A107 · Held by 2 superinvestors · Combined value: $2,428,844
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $1,802,635 | 538,100 | ADD | +69,502 |
| 2 | Ken Griffin | 0.0% | $626,209 | 186,928 | ADD | +115,914 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +69,502 | +14.8% |
| Ken Griffin | ADD | +115,914 | +163.2% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +88,798 | +23.4% |
| Ken Griffin | REDUCE | -22,891 | -24.4% |
Who Owns QNCX? Superinvestor Holdings
QUINCE THERAPEUTICS INC is held by 2 tracked superinvestors, with a combined position value of $2 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.